Anteris Technologies Global (AVR) EBITDA Margin (2024 - 2026)
Anteris Technologies Global's (AVR) quarterly EBITDA Margin came in at 3072.05% in Q2 2026, up 30724.0% year-over-year from N/an in Q2 2025, and up 36.79% quarter-over-quarter from 4859.72% in Q1 2026.
Powered by 
Analysis
Anteris Technologies Global (AVR) EBITDA Margin (2024 - 2026) Analysis & Trends
Anteris Technologies Global (AVR) has reported EBITDA Margin for 3 consecutive years, with 3072.05% the latest figure, recorded in Q2 2026.
- On a quarterly basis, EBITDA Margin rose 30724.0% year-over-year to 3072.05% in Q2 2026; TTM through Jun 2026 was 4738.36%, a 131843.0% decrease from a year earlier, with the FY2025 full-year figure at 4908.21%, down 200876.0% from the prior year.
- EBITDA Margin was 3072.05% for Q2 2026 at Anteris Technologies Global, up from 4859.72% in the prior quarter.
- Over five years, EBITDA Margin peaked at 2321.8% in Q1 2024 and troughed at 9343.55% in Q4 2025.
- A 3-year average of 4169.94% and a median of 3648.28% in 2025 frame the typical range for EBITDA Margin.
- Across the five-year window, EBITDA Margin slumped 532881 bps in 2025 and jumped 30724 bps in 2026, its largest moves.
- Over 3 years, EBITDA Margin stood at 4014.74% in 2024, then slumped by 133 bps to 9343.55% in 2025, then surged by 67 bps to 3072.05% in 2026.
- The last three EBITDA Margin figures came in at 3072.05% (Q2 2026), 4859.72% (Q1 2026), and 9343.55% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 13.44% |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 33.60% |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 18.08% |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 25.18% |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 21.65% |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 29.48% |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | 0.40% |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 24.33% |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 19.15% |
| 10 | Anteris Technologies Global | 806.46 Mn | 806.46 Mn | 776,000.00 | -3,072.05% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -3,072.05% |
| Mar 31, 2026 | -4,859.72% |
| Dec 31, 2025 | -9,343.55% |
| Sep 30, 2025 | -5,189.98% |
| Jun 30, 2025 | -3,379.29% |
| Mar 31, 2025 | -3,917.27% |
| Dec 31, 2024 | -4,014.74% |
| Sep 30, 2024 | -2,678.41% |
| Jun 30, 2024 | -2,922.63% |
| Mar 31, 2024 | -2,321.80% |